New York, Feb 12, 2026, 08:31 EST — Premarket
- Shares up 3.4% premarket after a 17.5% jump in the prior session
- 2026 profit view trails Street even as sales beat and nuclear demand stays firm
- First dividend and a UF6 output expansion plan sharpen focus on cash returns and growth
Shares of Solstice Advanced Materials (SOLS.O) rose 3.4% to $77.47 in premarket trade, building on Wednesday’s 17.5% surge that took the stock to a $74.95 close. (Public)
The early move comes as investors weigh a softer 2026 profit outlook against a growth pitch tied to nuclear fuel services, data centers and semiconductor materials. Solstice, spun off from Honeywell (HON.O) in October, forecast 2026 adjusted earnings per share of $2.45 to $2.75, below analysts’ average estimate of $2.93, according to LSEG data cited by Reuters. (Reuters)
That matters now because the stock’s first full-year guide as a standalone company is setting the baseline on margins, not just demand. Management has argued the long-term pull from AI-driven data centers and nuclear power is intact, but the company is still working through cost and mix headwinds in refrigerants and other lines.
Solstice said fourth-quarter net sales rose 8% to $987 million, while adjusted standalone EBITDA — earnings before interest, taxes, depreciation and amortisation — fell 20% to $189 million as margins narrowed to 19.1%. It guided 2026 net sales to $3.9 billion to $4.1 billion, adjusted EBITDA to $975 million to $1.025 billion, and capital spending of $400 million to $425 million; first-quarter adjusted EBITDA was pegged at $235 million to $245 million. (PR Newswire)
The company also moved to start paying shareholders. Solstice said its board declared a quarterly dividend of 7.5 cents a share, payable March 10 to holders of record on Feb. 24. (PR Newswire)
In a separate announcement earlier this week, Solstice said its Metropolis Works facility in Illinois is projected to produce over 10 kilotonnes of uranium hexafluoride (UF6) in 2026, about a 20% increase from planned 2024 capacity. The company said it has a backlog of more than $2 billion, is exploring further debottlenecking and new capacity investments with support in part from the U.S. Department of Energy, and said ConverDyn — a partnership with General Atomics — remains the exclusive marketing agent for UF6 produced at the site. (Stock Titan)
UF6 is an intermediate chemical used to prepare uranium for enrichment, a step utilities need before fuel can be fabricated for reactors. A bigger U.S. supply matters to buyers trying to line up long-term contracts, and it can also turn into choppy earnings if outages or regulatory constraints hit the plant.
The near-term pushback is still the margin picture. Solstice has flagged higher operating costs, plant downtime and the shift toward low-global-warming-potential refrigerants — alternatives designed to cut climate-warming impact — as drags that can linger even when volumes rise.
Traders will be watching whether Thursday’s gains hold after the opening bell, and whether management can deliver against its first-quarter targets as a check on that margin recovery. The next calendar markers are the Feb. 24 dividend record date and any added detail on timing and spending for the Metropolis capacity work.
